MedTrace Logo

AusCADASIL: An Australian Cohort of CADASIL

NCT06148051 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-05-08

No results posted yet for this study

Summary

The aim of this project is to establish an Australian cohort of patients diagnosed with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). This study will examine the clinical features and longitudinal course of CADASIL. Outcome measures include neuropsychological profile, neuroimaging, genetics, blood biomarkers, and retinal imaging.

Conditions

  • Cadasil

Sponsors & Collaborators

  • Prince of Wales Hospital, Sydney

    collaborator OTHER_GOV

  • John Hunter Hospital

    collaborator OTHER_GOV

  • St Vincent's Hospital - Sydney, Australia

    collaborator OTHER

  • Royal Brisbane and Women's Hospital

    collaborator OTHER_GOV

  • Melbourne Health

    collaborator OTHER

  • The University of Queensland

    collaborator OTHER

  • Perminder Sachdev

    lead OTHER

Principal Investigators

  • Perminder S Sachdev, MBBS, MD, PhD, FRANZCP, FAAHMS · University of New South Wales

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-25
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06148051 on ClinicalTrials.gov